Daclizumab (Daclizumab)
Overview of Daclizumab
Daclizumab is a monoclonal antibodies that prevent T-lymphocytes proliferation. Daclizumab is used for prophylaxis of acute rejection in allogenic renal transplantation. Daclizumab is usually given in combination with ciclosporin and corticosteroid immunosuppression regimens.
Indication of Daclizumab
Daclizumab is primarily indicated in conditions like Metastatic.
Contraindication of Daclizumab
Daclizumab is contraindicated in conditions like Pregnancy,Breast feeding.
Side Effects of Daclizumab
The severe or irreversible adverse effects of Daclizumab, which give rise to further complications include Peripheral edema, Cardiac arrest, Anaphylactic reactions, Lymphoproliferative disorders, Respiratory failure, Laryngeal oedema.,The symptomatic adverse reactions produced by Daclizumab are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Fatigue, Rashes, Urticaria, Tremor, Hypersensitivity reactions, Bronchospasm, Hypertension, Wheezing, GI disturbance, Burnning sensation of hands, and feets.
Precautions of Daclizumab
Precautions